Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes. Cytoreductive surgery and hyperthermic intraperitonea...

Full description

Bibliographic Details
Main Authors: Falla-Zuniga Luis Felipe, Sardi Armando, King Mary Caitlin, Lopez-Ramirez Felipe, Barakat Philipp, Nieroda Carol, Diaz-Montes Teresa, Gushchin Vadim
Format: Article
Language:English
Published: De Gruyter 2023-12-01
Series:Pleura and Peritoneum
Subjects:
Online Access:https://doi.org/10.1515/pp-2023-0019
_version_ 1827298434441281536
author Falla-Zuniga Luis Felipe
Sardi Armando
King Mary Caitlin
Lopez-Ramirez Felipe
Barakat Philipp
Nieroda Carol
Diaz-Montes Teresa
Gushchin Vadim
author_facet Falla-Zuniga Luis Felipe
Sardi Armando
King Mary Caitlin
Lopez-Ramirez Felipe
Barakat Philipp
Nieroda Carol
Diaz-Montes Teresa
Gushchin Vadim
author_sort Falla-Zuniga Luis Felipe
collection DOAJ
description There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is an effective treatment for PM of non-gynecologic origin and, recently, epithelial ovarian cancer. We evaluated the feasibility of CRS/HIPEC in the management of PM from rare ovarian malignancies and report postoperative outcomes on these patients.
first_indexed 2024-04-24T15:15:51Z
format Article
id doaj.art-44e4a78cc716425e97548b0fd124cce7
institution Directory Open Access Journal
issn 2364-768X
language English
last_indexed 2024-04-24T15:15:51Z
publishDate 2023-12-01
publisher De Gruyter
record_format Article
series Pleura and Peritoneum
spelling doaj.art-44e4a78cc716425e97548b0fd124cce72024-04-02T09:20:56ZengDe GruyterPleura and Peritoneum2364-768X2023-12-0191152210.1515/pp-2023-0019Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)Falla-Zuniga Luis Felipe0Sardi Armando1King Mary Caitlin2Lopez-Ramirez Felipe3Barakat Philipp4Nieroda Carol5Diaz-Montes Teresa6Gushchin Vadim7Surgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USASurgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USASurgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USASurgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USASurgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USASurgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USAGynecological Oncology, The Lya Segall Ovarian Cancer Institute, Mercy Medical Center, Baltimore, MD, USASurgical Oncology, Institute for Cancer Care at Mercy, Mercy Medical Center, Baltimore, MD, USAThere are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is an effective treatment for PM of non-gynecologic origin and, recently, epithelial ovarian cancer. We evaluated the feasibility of CRS/HIPEC in the management of PM from rare ovarian malignancies and report postoperative outcomes on these patients.https://doi.org/10.1515/pp-2023-0019peritoneal neoplasmscytoreduction surgical procedureshyperthermic intraperitoneal chemotherapyovarian neoplasms
spellingShingle Falla-Zuniga Luis Felipe
Sardi Armando
King Mary Caitlin
Lopez-Ramirez Felipe
Barakat Philipp
Nieroda Carol
Diaz-Montes Teresa
Gushchin Vadim
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
Pleura and Peritoneum
peritoneal neoplasms
cytoreduction surgical procedures
hyperthermic intraperitoneal chemotherapy
ovarian neoplasms
title Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
title_full Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
title_fullStr Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
title_full_unstemmed Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
title_short Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
title_sort peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy crs hipec
topic peritoneal neoplasms
cytoreduction surgical procedures
hyperthermic intraperitoneal chemotherapy
ovarian neoplasms
url https://doi.org/10.1515/pp-2023-0019
work_keys_str_mv AT fallazunigaluisfelipe peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT sardiarmando peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT kingmarycaitlin peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT lopezramirezfelipe peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT barakatphilipp peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT nierodacarol peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT diazmontesteresa peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec
AT gushchinvadim peritonealmetastasesfromrareovariancancertreatedwithcytoreductivesurgeryandhyperthermicintraperitonealchemotherapycrshipec